Literature DB >> 16511643

Mononeuropathy following subcutaneous interferon-beta injection.

M Capasso, M Caulo, G De Luca, N Magarelli, A Lugaresi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16511643     DOI: 10.1007/s00415-006-0136-9

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  7 in total

1.  Severe necrotising cutaneous lesions complicating treatment with interferon beta-1a.

Authors:  A J Radziwill; S Courvoisier
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-07       Impact factor: 10.154

2.  Focal neuropathy associated with cutaneous necrosis at the site of interferon-beta injection for multiple sclerosis.

Authors:  A Créange; J P Lefaucheur
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-03       Impact factor: 10.154

3.  Cutaneous reactions to recombinant human interferon beta-1b: the clinical and histologic spectrum.

Authors:  G W Elgart; W Sheremata; Y S Ahn
Journal:  J Am Acad Dermatol       Date:  1997-10       Impact factor: 11.527

4.  Cutaneous necrosis associated with recombinant interferon injection. Report of three cases with interferon beta-1b and review of the literature.

Authors:  J M Weinberg; J T Wolfe; S Sood; M Saruk; A H Rook; E M Spiers
Journal:  Acta Derm Venereol       Date:  1997-03       Impact factor: 4.437

Review 5.  Multiple sclerosis: side effects of interferon beta therapy and their management.

Authors:  E U Walther; R Hohlfeld
Journal:  Neurology       Date:  1999-11-10       Impact factor: 9.910

6.  Cutaneous necrosis associated with interferon alpha-2b.

Authors:  J B Sickler; R A Simmons; D K Cobb; K E Sherman
Journal:  Am J Gastroenterol       Date:  1998-03       Impact factor: 10.864

7.  [Activated C protein resistance manifested by cutaneous necrosis after interferon alpha injection: case report].

Authors:  F Plurien; Z Le Lostec; C Pauwels; Y Welker; C Glaser; P de Mazancourt; J Y Peltier; P Mornet
Journal:  Rev Med Interne       Date:  2000-09       Impact factor: 0.728

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.